Compare Huntington Bancshares Incorporated (HBAN) vs Nuwellis Inc (NUWE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Huntington Bancshares Incorporated vs Nuwellis Inc — how do they compare? Huntington Bancshares Incorporated trades at $15.29 (market cap $31.04B), while Nuwellis Inc trades at $0.7 (market cap $2.20M). The key difference: Huntington Bancshares Incorporated is far larger — about 14109.1× Nuwellis Inc's market cap, and Huntington Bancshares Incorporated pays a 4.04% dividend while Nuwellis Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Huntington Bancshares Incorporated for 52 Days and Nuwellis Inc for 26 Days on average.
| HBAN | NUWE | |
|---|---|---|
Market Cap | $31.04B | $2.20M |
Volume | 23,864,172 | 121,544 |
Sector | Financials | Health |
52-Week High | $19.27 | $146.65 |
52-Week Low | $15.02 | $0.68 |
Typical Hold Time | 52 Days | 26 Days |
Enterprise Value | $49.57B | -$1.52M |
Dividend Yield | 4.04% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Huntington Bancshares (HBAN) trades at $15.17, down 1.04% on the day, with a bearish technical signal. The company reported mixed quarterly earnings, missing in Q4 2025 and Q2 2026 but beating in Q1 2026, while revenue grew to $8.13B in 2025. Analyst consensus is split evenly between Buy and Hold, with a $19.60 price target suggesting upside. Recent news highlights margin pressures from higher interest rates and a revised 2027 outlook.
HBAN offers value with a P/E of 11.82 and pays a dividend, but faces headwinds from net interest margin compression and loan growth challenges. The stock's near-term performance hinges on Q3 2026 earnings and management's ability to navigate rate environment pressures.
NUWE trades at $0.6907, down 1.48% on the day, with a bearish technical signal from moving averages despite oversold RSI readings. The company reported revenue growth to $9M in 2026 but remains deeply unprofitable with a net income margin of -125.63%. Recent news highlights console sales growth and strategic expansions in pediatric and critical care markets.
The outlook is high-risk due to persistent losses and negative cash flow, though analyst sentiment is split with a 50% buy rating. Investment potential hinges on the company's ability to achieve profitability and scale its Aquadex platform, while risks include cash burn and competitive pressures in the medical device sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Huntington Bancshares Incorporated
Huntington Bancshares is a regional bank holding company headquartered in Columbus, Ohio. The bank has a network of branches and ATMs across eight Midwestern states. Founded in 1866, Huntington National Bank and its affiliates provide consumer, small-business, commercial, treasury management, wealth management, brokerage, trust, and insurance services. Huntington also provides auto dealer, equipment finance, national settlement, and capital market services that extend beyond its core states.
Read more on HBAN →About Nuwellis Inc
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →
